Anti-secretory properties of non-peptide somatostatin receptor agonists in isolated rat colon: Luminal activity and possible interaction with p-glycoprotein

British Journal of Pharmacology

Volumn 135, Issue 6, 2002, Pages 1443-1448

  Emery, P T J ^a   Higgs, N B ^a   Warhurst, A C ^a   Carlson, G L ^a   Warhurst, G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

L 779,976; Octreotide; Secretory diarrhoea; Somatostatin

Indexed keywords

ANTIDIARRHEAL AGENT; CHLORIDE; ELACRIDAR; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; L 779976; L 796778; L 797591; L 803807; L 817818; OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 1 AGONIST; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 2 AGONIST; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 3 AGONIST; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 4 AGONIST; SOMATOSTATIN RECEPTOR 5; SOMATOSTATIN RECEPTOR 5 AGONIST; SOMATOSTATIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; BIOASSAY; CHLORIDE TRANSPORT; COLON MUCOSA; COLON SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIARRHEA; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; INHIBITION KINETICS; INTESTINE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSTATIN RELEASE;

EID: 0036217575     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704614     Document Type: Article

References (32)

1. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans
2. Cellular biology of somatostatin receptors
3. Reversal of resistance by GF120918 in cells expressing the ABC half-transporter, MXR
4. Chronic diarrhoea: Current concepts on mechanisms and management
5. Non-peptidic ligands for peptide and protein receptors
6. Intestinal absorption of the octapeptide SMS-201-995 visualised by fluorescence derivatisation
7. Oral absorption of the somatostatin analogue SMS 201-995: Theoretical and practical implications
8. In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis
9. P-glycoprotein and MRP-2 mediated octreotide transport in renal proximal tubule
10. Somatostatin enhances cAMP-dependent short-circuit current in human colon via somatostatin receptor subtype-2
11. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan
12. Efflux of taurocholic acid across the blood brain barrier: Interaction with cyclic peptides
13. Effect of the somatostatin analogue (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men
14. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat
15. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa
16. Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
17. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue
18. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine
19. Neuroendocrine gastrointestinal tumours
20. Long-acting octreotide is effective in controlling re-bleeding angiodysplasia of the gastrointestinal tract
21. Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclisation
22. Somatostatin and its receptor family
23. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin
24. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
25. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: Peptide binding and effects on drug transport and accumulation
26. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial
27. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics
28. Influence of short term octreotide administration on chronic tissue injury, transforming growth factor beta (TGF-beta) overexpression, and collagen accumulation in irradiated rat intestine
29. - secretion in HT-29cl.19A colonocytes
30. Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon
31. Characterisation of the transport of a cationic octapeptide, octreotide, in rat bile canalicular membrane: Possible involvement of P-glycoprotein
32. Octreotide in the treatment of severe chemotherapy-induced diarrhoea